Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial

Credit: Veuer

Duration: 01:13s 14 Jun 2021 0 shares 6 views

Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial

The American biotechnology company Novavax is set to offer the US a fourth COVID-19 vaccine.

Veuer’s Maria Mercedes Galuppo has the story.

You might like

Related news coverage

Powerful New COVID Vaccine

Powerful New COVID Vaccine

TomoNews US 17 Jun 2021

GAITHERSBURG, MARYLAND — A powerful new COVID-19 vaccine from Novavax uses a different approach from previous vaccines and has..

Possible 4th vaccine option announced today

Possible 4th vaccine option announced today

FOX 4 Now Florida

15 Jun 2021

Novavax Vaccine, Studied In Colorado, Said To Be More Than 90% Effective

Novavax Vaccine, Studied In Colorado, Said To Be More Than 90% Effective

CBS 4 Denver

14 Jun 2021

Novavax Announces Promising Late-Stage Covid-19 Vaccine Data, More Than 90% Effective

Novavax Announces Promising Late-Stage Covid-19 Vaccine Data, More Than 90% Effective

WJZ Baltimore

14 Jun 2021

Novavax: Large Study Finds COVID-19 Shot About 90% Effective

Novavax: Large Study Finds COVID-19 Shot About 90% Effective

WJZ Baltimore

14 Jun 2021

Advertisement

More coverage

Novavax Covid vaccine found 90% effective against Covid and its variants| Oneindia News

Novavax Covid vaccine found 90% effective against Covid and its variants| Oneindia News

Shares of six listed Adani Group companies tumbled on the stock market after a report suggested that the National Securities..

Oneindia 14 Jun 2021

Novavax vaccine over 90% effective in U.S. trial

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective..

Reuters - Politics 14 Jun 2021